Bureaucrats, developer, Administrators
9,842
edits
User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions
User:Jukeboksi/Wiki.study/Natural therapeutics (edit)
Revision as of 12:00, 16 July 2020
, 16 July 2020→Brain cancer and cannabis: + a 2009 '''clinical trial''', published in w:Neuropharmacology (journal) titled 'Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?'
(→Brain cancer and cannabis: + a 2004 '''review''', published in w:Neuropharmacology (journal) titled 'Hypothesis: cannabinoid therapy for the treatment of gliomas?') |
(→Brain cancer and cannabis: + a 2009 '''clinical trial''', published in w:Neuropharmacology (journal) titled 'Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?') |
||
| Line 218: | Line 218: | ||
* [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h4 'Cannabis Therapeutics and the Future of Neurology: Cannabis and Brain Tumors'], a 2018 perspective article | * [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h4 'Cannabis Therapeutics and the Future of Neurology: Cannabis and Brain Tumors'], a 2018 perspective article | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/20307616 'Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2010 comparative study, published in [[w:Neurochemistry International]] | * [http://www.ncbi.nlm.nih.gov/pubmed/20307616 'Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2010 comparative study, published in [[w:Neurochemistry International]] | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/17675107 'Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 '''clinical trial''', published in [[w:Neuropharmacology (journal)]] | |||
* [http://www.ncbi.nlm.nih.gov/pubmed/19480992 'Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 study, published in [[w:Brain Research Bulletin]] | * [http://www.ncbi.nlm.nih.gov/pubmed/19480992 'Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 study, published in [[w:Brain Research Bulletin]] | ||
* [http://www.ncbi.nlm.nih.gov/pubmed/17952650 'Cannabinoids and gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2007 '''review''', published in [[w:Molecular Neurobiology (journal)]] | * [http://www.ncbi.nlm.nih.gov/pubmed/17952650 'Cannabinoids and gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2007 '''review''', published in [[w:Molecular Neurobiology (journal)]] | ||